| Analysis | Metabolite Name | Measured Value | Units | Sample source | Age | Genotype | Treatment |
|---|---|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 123.721881 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 129.518072 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 141.104294 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 142.126789 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 142.570281 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 146.542828 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 149.598394 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 149.638803 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 174.975562 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 175.438596 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 188.528678 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 203.323558 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 205.499276 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 207.428847 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 212.827988 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 219.769674 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 219.971056 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 230.42394 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 242.424242 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 243.926142 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 245.869776 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 249.376559 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 260.956175 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 262.948207 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 270.214944 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 273.201251 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 274.244004 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 279.880478 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 292.732856 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 310.940499 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 313.868613 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 314.227226 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 315.684316 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 326.262626 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 334.665335 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 341.658342 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 356.565657 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 364.683301 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 399.804497 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 412.512219 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 433.040078 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 451.327434 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 452.525253 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 467.935872 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 471.943888 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 481.809243 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 521.042084 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PC(18:2_18:2) | 585.054081 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|